Presentation

Academic

  • Invited lecture to the University of Illinois at Chicago entitled 'Alpha 6-integrin as a therapeutic target in endocrine therapy resistant breast cancer' (12/2020)
  • Research in Progress seminar given at Loma Linda University entitled 'Alpha 6-integrin as a therapeutic target in endocrine therapy-resistant breast cancer' (01/2021)

Poster

  • Vickers H., Bravo B., Butler D., Figueroa J., Davis W., and Brantley E. The expression of activating transcription factor 3 (ATF-3) in 5F 203-mediated breast cancer cells.  Presented at the Loma Linda University summer research symposium sponsored by the Center or Health Disparities and Molecular Medicine. (08/2008)
  • E. Brantley, C. Watkins, L. McLean, L. Amis and W. Davis. 5F 203 modulates oxidative stress, induces single strand breaks and promote mitochondrial membrane potential loss in breast cancer cells. Poster presentation at the American Association for Cancer Research (AACR) meeting in Washington, DC. (04/2010)
  • Zylstra D., Marks B., Whitley R., Stelling C., Amis L., Brantley E. and Davis W. Antioxidants perturb the effectiveness of aminoflavone and benzothiazole treatment in breast cancer cell lines derived from African-American women.  Presented at the Science of Cancer Health Disparities American Association for Cancer Research meeting, (Carefree, AZ) (02/2009)
  • Davis W., Garispe E., Whitley R., Marks B., Stelling C., Zylstra D., Lucinian T., and Brantley E. Low Concentrations of Hydrogen Peroxide Induce Altered Physiology of Human Diploid Fibroblasts. Presented at the Annual FASEB meeting in New Orleans, LA. (04/2009)
  • McLean L., Davis, W.L., Jr., Sowers L. and Brantley E. 5F 203-induced apoptosis involves oxidative stress and caspase activation in sensitive breast cancer cells. Presented at the 99th Annual American Association for Cancer Research meeting, San Diego, CA. (04/2008)
  • Brantley, E., Amis L. and Davis, W.L., Jr. Apigenin augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients.  Presented at the Science of Cancer Health Disparities American Association for Cancer Research meeting, Atlanta, GA. (11/2007)
  • Jimenez R., Amis L., Davis W., and Brantley E. Aminoflavone-induced anticancer activity is attenuated in MDA-MB-468 human breast cancer cells pretreated with the DNA methyltransferase inhibitor 5aza-2''''deoxycitidine. Presented at Loma Linda University research symposium sponsored by the Center for Health Disparities and Molecular Medicine (08/2007)
  • Jimenez R. and Brantley E. Aminoflavone modulates reactive oxygen species formation in a cytochrome P450 1A-dependent manner in estrogen receptor negative MDA-MB-468 breast cancer cells. Presented at the Loma Linda University research symposium sponsored by the Center for Health Disparities and Molecular Medicine (07/2006)

Other

  • Lancelot McLean, Carlos Casiano, Ubaldo Soto, Lawrence Sowers and Eileen Brantley. Growth inhibitory effects of Aminoflavone in estrogen receptor negative MDA-MB-468 breast cancer cells . Presented at the 2006 Annual American Association for Cancer Research meeting. Washington, D.C. (04/2006)

Research

  • A seminar presentation entitled "An Account of the Preclinical Evaluation of Phortress as an Anticancer Agent" was given on October 11, 2007 at Loma Linda University. (10/2007)
  • 'miR135a-5p as a potential therapeutic target for tamoxifen resistant breast cancer' given as a research in progress seminar (07/2018)
  • Jonathan Wooten, Shaniece Wauchope, Nicole Mavingire, and Eileen Brantley. Plant isolate dibenzyl trisulfide potently inhibits cytochrome P450 1 enzyme activity and the growth of breast cancercells derived from African American patients.  11th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. November 2018 (11/2018)
  • Eileen Brantley, Nicole Mavingire, Jonathan Wooten and Petreena Campbell. Aryl hydrocarbon receptor ligands 5F 203 and 3,3'-Diindolylmethane disrupt mammospheres derived from MCF-7 cells and induce tumor suppressor miR125b-2 expression. Annual American Association for Cancer Research meeting, April 2019 (03/2019 - 04/2019)
  • Jonathan Wooten, Nicole Mavingire, Petreena Campbell and Eileen Brantley. Aryl hydrocarbon receptor ligands 5F 203 and 3,3'-Diindolylmethane disrupt mammospheres derived from MCF-7 cells and induce tumor suppressor miR125b-2 expression. Annual American Association for Cancer Research meeting, April 2019 (03/2019 - 04/2019)
  • Annual American Association for Cancer Research Meeting (virtual)-poster presentation Plant power: Plant isolate dibenzyl trisulfide induces death of triple-negative breast cancer cells derived from an African American patient. Wooten, J., Araujo, C., Mavingire, N., Wauchoppe, S. Delgoda T. and Brantley, E. (06/2020)